| 摘要 |
<p>The invention concerns a peptide compound, causing a T specific response from tumours, comprising a sequence of at least 8 consecutive amino acids of the peptide sequence coded by a phase offset sequence of the iCE gene. The invention also concerns a pharmaceutical composition comprising said peptide compound and the use of said compounds for making a medicine for cancer treatment, in particular for treating solid tumours.</p> |
